Toxicity and Outcomes Associated with Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Sarcomatosis

By Lim Sherry   Cormier Janice   Feig Barry   Mansfield Paul   Benjamin Robert   Griffin Janet   Chase Judy   Pisters Peter   Pollock Raphael   Hunt Kelly  

Annals of Surgical Oncology, Vol. 14, Iss. 8, 2007-08 ,pp. : 2309-2318

Springer Publishing Company

Access to resources Recommend Favorite

A Systematic Review on the Efficacy of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei

By Yan Tristan   Black Deborah   Savady Renaldo   Sugarbaker Paul  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 484-492

Springer Publishing Company

Access to resources Recommend Favorite

Peritoneal Sarcomatosis: Is There a Subset of Patients Who May Benefit from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?

By Baratti Dario  

Annals of Surgical Oncology, Vol. 17, Iss. 12, 2010-12 ,pp. : 3220-3228

Springer Publishing Company

Access to resources Recommend Favorite

Intraperitoneal chemotherapy for the treatment of ovarian cancer

By Dorff Tanya  

The Women's Oncology Review, Vol. 5, Iss. 4, 2005-12 ,pp. : 203-211

Informa Healthcare

Access to resources Recommend Favorite

Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: A systematic review and meta-analysis of randomised controlled trials

By Mi Deng-Hai   Li Zheng   Yang Ke-Hu   Cao Nong   Lethaby Anne   Tian Jin-Hui   Santesso Nancy   Ma Bin   Chen Yao-Long   Liu Ya-Li  

International Journal of Hyperthermia, Vol. 29, Iss. 2, 2013-03 ,pp. : 156-167

Informa Healthcare

Access to resources Recommend Favorite